In addition to freely accessing all journal content on our website, users can participate in our online biomedical research
Our editorial staff continues to keep Molecular Medicine
at the forefront of the publishing world. We place high priority on rapid peer review and publication. Average time to first decision is approximately four weeks and all accepted content is published free online without embargo. We automatically submit your content to PubMed Central
according to the NIH Public Access Policy
, alleviating authors of this burden. We also provide a pre-submission enquiry service
if authors are unsure as to whether or not their manuscript comes within the scope of Molecular Medicine.
Published by The Feinstein Institute Press
, Molecular Medicine
is a successful open access journal with an impact factor of 3.530. It currently ranks amongst the top 15% of more than 8,000 international peer-reviewed journals in the Thomson Reuter’s Journal Citation Reports
®. JCR category rankings are as follows: Medicine, Research & Experimental 32/124, Cell Biology 83/187, Biochemistry & Molecular Biology 97/289. We have made great strides since 1994 and look forward to continued growth during these exciting times in molecular science.